Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Prognostic Model for Drug-induced Liver Injury in China
Sponsor: Beijing Friendship Hospital
Summary
A prospective, multi-center, non-interventional cohort study is going to conduct to explore the clinical characteristics, culprit drug(s) or herb(s), outcomes and risk factors of Drug-induced liver injury (DILI) in China and screen novel serum markers. A prognostic model incorporating with the novel serum marker(s) for DILI would be established and validated to imporve the prognosis of patients in China .
Official title: A Prognostic Model for Drug-induced Liver Injury in China : A Multi-center, Prospective Cohort Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
3000
Start Date
2022-05-25
Completion Date
2028-12-31
Last Updated
2025-09-22
Healthy Volunteers
No
Conditions
Locations (13)
Beijing 302 Hospital
Beijing, Beijing Municipality, China
Beijing Friendship Hospital, Capital Medical University
Beijing, China
Beijing You 'an Hospital, Capital Medical University
Beijing, China
Beijing Ditan Hospital
Beijing, China
Peking University Third Hospital
Beijing, China
The Second Affiliated Hospital of Dalian Medical University
Dalian, China
Qinzhou First People's Hospital
Guangxi, China
Hebei CNPC Central Hospital
Hebei, China
Jiaozuo People's Hospital
Jiaozuo, China
The Second Hospital of Lanzhou University
Lanzhou, China
The Affiliated Hospital of Qingdao University
Qingdao, China
Qinghai People's Hospital
Qinghai, China
Yuncheng Central Hospital
Yuncheng, China